Literature DB >> 17656596

Differences and similarities regarding adiponectin investigated in African and Caucasian women.

Aletta E Schutte1, Hugo W Huisman, Rudolph Schutte, Leoné Malan, Johannes M van Rooyen, Nico T Malan, Peter E H Schwarz.   

Abstract

OBJECTIVE: Concentrations of adiponectin, an adipocytokine with insulin-sensitizing actions, may vary according to ethnic group. This study aimed to determine whether fasting adiponectin levels of Caucasian and African women differ. A second objective was to determine which components of the metabolic syndrome are more closely related to adiponectinemia in both groups.
DESIGN: A cross-sectional study including 102 urban African and 115 Caucasian women with a wide range of obesity aged 20-55 years.
METHODS: Anthropometric measurements were taken, namely weight, height, body mass index, waist circumference, and hip circumference. Cardiovascular measurements included blood pressure and arterial compliance. Fasting blood samples were taken to determine glucose, insulin, C-peptide, leptin, adiponectin, and lipid levels.
RESULTS: Mean adiponectin levels of the whole groups did not differ, but normal weight African women (N = 38) showed marginally lower adiponectin levels than their Caucasian counterparts (N = 41; P = 0.047). No differences in adiponectin were shown for overweight and obese women. Separate multiple regression analyses for ethnic groups showed that only homeostasis model assessment-insulin resistance (HOMA-IR) significantly contributed to the variance in adiponectin levels of African women, whereas leptin, triacylglycerol levels and HOMA-IR contributed significantly to adiponectin variance in Caucasian women. An additional multiple regression analysis in a combined ethnic group (N = 217) showed ethnicity to be a significant contributor to variances in adiponectin levels.
CONCLUSIONS: Even though adiponectin levels of these ethnic groups are similar, different associations of adiponectin with leptin and triacylglycerol levels might indicate that there are ethnic differences regarding the mechanistic functions of adiponectin within the scope of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656596     DOI: 10.1530/EJE-07-0044

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  16 in total

1.  Ethnic and Sex Differences in Adiponectin: From Childhood to Adulthood.

Authors:  Rebecca A Ohman-Hanson; Melanie Cree-Green; Megan M Kelsey; Daniel H Bessesen; Teresa A Sharp; Laura Pyle; Rocio I Pereira; Kristen J Nadeau
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

2.  Associations of body mass index and insulin resistance with leptin, adiponectin, and the leptin-to-adiponectin ratio across ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Laura J Rasmussen-Torvik; Christina L Wassel; Jingzhong Ding; Jeffery Carr; Mary Cushman; Nancy Jenny; Matthew A Allison
Journal:  Ann Epidemiol       Date:  2012-08-25       Impact factor: 3.797

3.  Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.

Authors:  Hannah Gardener; Milita Crisby; Charlotte Sjoberg; Barry Hudson; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Metab Syndr Relat Disord       Date:  2012-11-05       Impact factor: 1.894

Review 4.  Evolutionary forces in diabetes and hypertension pathogenesis in Africans.

Authors:  Karlijn A C Meeks; Amy R Bentley; Adebowale A Adeyemo; Charles N Rotimi
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

5.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

6.  Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures.

Authors:  Rocio I Pereira; Cecilia Cl Wang; Patrick Hosokawa; L Miriam Dickinson; Michel Chonchol; Mori J Krantz; John F Steiner; Daniel H Bessesen; Edward P Havranek; Carlin S Long
Journal:  BMC Endocr Disord       Date:  2011-07-07       Impact factor: 2.763

7.  Adiponectin is not associated with blood pressure in normotensives and untreated hypertensives with normal kidney function.

Authors:  Vanja Ivković; Mislav Jelaković; Mario Laganović; Ivan Pećin; Ana Vrdoljak; Sandra Karanović; Mirjana Fuček; Tamara Božina; Jelena Kos; Tajana Željković Vrkić; Vedran Premužić; Marijana Živko; Bojan Jelaković
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

8.  Ethnic differences in the association between waist-to-height ratio and albumin-creatinine ratio: the observational SUNSET study.

Authors:  Irene G M van Valkengoed; Charles Agyemang; Ray T Krediet; Karien Stronks
Journal:  BMC Nephrol       Date:  2012-05-07       Impact factor: 2.388

9.  Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women.

Authors:  Thea Scantlebury-Manning; Joseph Bower; Katherine Cianflone; Hisham Barakat
Journal:  Nutr Metab (Lond)       Date:  2009-04-17       Impact factor: 4.169

10.  Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.

Authors:  Eric M Ndombi; Valentine Budambula; Mark K Webale; Francis O Musumba; Jesca O Wesongah; Erick Mibei; Aabid A Ahmed; Raphael Lihana; Tom Were
Journal:  Endocr Connect       Date:  2015-08-25       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.